看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
4 i$ |- C6 K2 m6 |4 d8 k& p2 d8 c+ ]4 u
[3 q5 @) y$ T' _1 d* n
Currently available feasibility data for possible combination strategies.
4 j* @) Z( u n" x0 B, b) M————————————————————————————————9 t7 b% I. r C7 r% z% p' f
Combination Feasibility according to preliminary data # O1 D8 T( N1 G) B
——————————————————————————————————
8 l; q( Q8 F; A+ z8 W$ W5 bBevacizumab + sorafenib Yes, reduced dose 4 X# [! ^+ v2 P6 g
Bevacizumab + sunitinib† No
! y" T5 T9 ?& F8 @1 I8 WBevacizumab + temsirolimus Yes , q3 N; |9 u7 W" R G8 Y
Bevacizumab + everolimus Yes 6 U/ \9 w8 Y/ L, Q6 n) F3 p* U" j
Sorafenib + sunitinib ?
% f8 i8 l& h0 Q9 ?& ?" KSorafenib + temsirolimus Yes, reduced dose
: V9 W9 d( d6 ]( uSorafenib + everolimus Yes, reduced dose
& s8 Z* X7 D0 V# |& i0 z- {Sunitinib + temsirolimus† No 0 u8 [: G& B, }- W. L x7 a
Sunitinib + everolimus ? j6 `2 z/ @8 f* X6 f. t) ]0 H
Temsirolimus + everolimus ? " u/ t* S# O9 [# @
————————————————————
2 \, s5 r: |- R" M" @% ~: T2 `2 ]†Led to US FDA warning.8 d0 l/ n6 X- I! s
?: As yet unattempted combination.
$ j9 Q8 ~5 E- `! y |